LawrenceStanberryMDPhD

Pediatric Infectious Disease • New York, NY

Pediatric Travel and Tropical Medicine, Pediatric Vaccinology and Vaccine Preventable Diseases, Perinatal Infections

Professor of Pediatrics, Associate Dean for International Programs, Columbia University

Join to view full profile

Dr. Stanberry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stanberry's full profile

Already have an account?

Office
622 West 168th Street
PH17, Room 101, Department of Pediatrics
New York, NY 10032
Phone+1 212-305-2229

Summary

Dr. Stanberry is the Associate Dean for International Programs, Director of the Programs in Global Health and Co-Director of the Program in Vaccine Education at Columbia University’s Vagelos College of Physicians and Surgeons.
His previous positions include Chairman of Pediatrics, Columbia University (2008-2018); Chairman of Pediatrics and Director, Sealy Center for Vaccine Development, University of Texas Medical Branch at Galveston (2000–2008); and the Albert Sabin Professor of Pediatrics and Director of Infectious Diseases at Cincinnati Children’s Medical Center (1995–2000).
Dr. Stanberry received M.D. and Ph.D. (Pharmacology) from the University of Illinois. His postgraduate medical training was in Pediatrics, Infectious Diseases, and Virology at University of Texas Southwestern Medical School and University of Utah. Dr. Stanberry is an authority on viral diseases including emerging infectious diseases, perinatal infections, and vaccine and antiviral drug development.
He has served on numerous advisory boards and review panels including serving as chair of the Vaccine Study Section and the Pediatrics Review Panel at NIH. His research funding has come from the NIH, Centers for Disease Control and Prevention, numerous vaccine, pharmaceutical and biotech companies, and the Bill and Melinda Gates Foundation.
Dr. Stanberry has authored over 200 scientific articles and authored or edited nine books including “Vaccines for Biodefense and Emerging and Neglected Diseases, (1st edition 2009, 2nd edition anticipated 2020), “Understanding Modern Vaccines” (2011) and “Viral Infections of Humans: Epidemiology and Control,” (5th edition 2014, 6th edition is currently in production).
His current work focuses on the preparedness of children’s hospitals globally to prevent, detect, and respond to infections with pandemic potential, the effects of extreme heat on children's health in Africa and scalably approaches to addressing vaccine hesitancy.

Education & Training

University of Utah HealthFellowship, Pediatric Infectious Diseases, 1980 - 1982
University of Utah HealthResidency, Pediatrics, 1979 - 1980
University of Chicago Medical CenterPh.D., Pharmacology, 1979
University of Chicago Medical CenterPhD, Pharmacology, 1979
University of Texas Southwestern Medical Center/Children's HealthInternship, Transitional Year, 1977 - 1978
University of Illinois College of MedicineClass of 1977
Southwestern UniversityB.S., Chemistry, 1970

Certifications & Licensure

NY State Medical License 2008 - 2026
OH State Medical License 1982 - 2014
TX State Medical License 2003 - 2012
IL State Medical License 1978 - 1982
UT State Medical License 1980 - 1982
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

Distinguished Service to Children Award 1199SIEU/Employer Child Care Corporation, 2011
Citation of Merit Alumni Association, Southwestern University, 2009
Lowell A Glasgow Visiting Professorship 2009 University of Utah and American Academy of Pediatrics Utah Chapter, 2009
Lowell A Glasgow Visiting Professorship University of Utah and American Academy of Pediatrics Utah Chapter, 2009
Rueben S. Carpentier Professor College of Physicians and Surgeons, Columbia University, 2008
Member, Alpha Omega Alpha Honor Medical Society 2004
Alpha Omega Alpha 2004
Osofsky Visiting Professorship Children's Hospital, New Orleans, LA, 2002
Inducted into the Hall of Honor Cincinnati Pediatric Historical Society, 2002
John Sealy Distinguished Chair and Professor University of Texas Medical Branch, 2002
Highly Commended Prize in the Public Health Section British Medical Association Book Awards, 2001
Book Awards Highly Commended Prize in the Public Health Section British Medical Association, 2001
Keynote Address: Management Issues in Genital Herpes The Medical (British) Society for the Study of Venereal Diseases, 1998
Mead-Johnson Award for Excellence in Teaching Children's Hospital Medical Center, 1998
The Albert B. Sabin Chair of Pediatrics Children's Hospital Research Foundation, 1996
Faculty Achievement Award University of Cincinnati, 1995
The Pauline and Lawson Reed Chair of Pediatric Infectious Diseases Children's Hospital Research Foundation, 1995
John A. Hartford Foundation Fellow Children's Hospital Research Foundation, 1984
National Institutes of Health Fellowship in Infectious Diseases University of Utah, 1980
National Institutes of Health Fellow in Infectious Diseases University of Utah, 1980
Research Prize University of Illinois College of Medicine, 1977
Clinical Oncology Fellowship University of Illinois Medical Center, 1976
Clinical Oncology Fellow University of Illinois Medical Center, 1976
James Scholar in Independent Study University of Illinois Medical Center, 1974
Michael A. Desmond Scholarship University of Illinois Medical Center, 1974
National Cancer Institute Fellowship University of Colorado, 1973
National Cancer Institute Fellow University of Colorado, 1973
U.S. Public Health Service Trainee in Pharmacology University of Illinois Medical Center, 1971
Join now to see all

Clinical Trials

Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System Start of enrollment: 1997 Jun 01
Unknown status
Phase 3

Publications & Presentations

PubMed

136 citations
Prospects for Control of Herpes Simplex Virus Disease through Immunization
Lawrence R. Stanberry, Anthony L. Cunningham, Adrian Mindel, Laurie L. Scott, Spotswood L. Spruance
Clinical Infectious Diseases. 2000-03-01
22 citations
Prioritizing the needs of children in a changing climate.
Lawrence R. Stanberry, Madeleine C. Thomson, Wilmot G. James
Plos Medicine. 2018-07-31
228 citations
Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.
Christine B. Turley, Richard E. Rupp, Casey P. Johnson, David N. Taylor, Julie Wolfson
Vaccine. 2011-07-18

Journal Articles

Prioritizing the Needs of Children in a Changing Climate
Lawrence Stanberry, MD, PLoS One
Chairs and their faculty: reducing "top" stress; enhancing "middle" leadership.
Rosenthal SL, Stanberry LR., J Pediatr. 2015 166(5):1105-6. doi: 10.1016/j.jpeds.2015.01.026, 5/2015
Current thinking on genital herpes
Hofstetter AM, Rosenthal SL, Stanberry LR, Curr Opin Infect Dis, 1/1/2014
Attitudes towards Microbicide Use for Bacterial Vaginosis in Pregnancy
Catalozzi M, Williams C, Zimet G, Gelber S, Ratner A, Stanberry L, Rosenthal S, Sexual Health, 1/1/2014
Adolescents' and Young Women's use of a microbicide surrogate product when receiving oral sex
Auslander BA, Catallozzi M, Davis G, Succop PA, Stanberry LR, Rosenthal SL, J Pediatr Adolesc Gynecol, 1/1/2013
Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W(80)5EC combined with approved seasonal influenza antigens
Stanberry LR, Simon JK, Johnson C, Robinson PL, Morry J, Flack MR, Gracon S, Myc A, Hamouda T, Baker JR Jr, Vaccine, 1/1/2012
Reducing the Stigma of Herpes Simplex Virus (HSV) Infection: Lessons from an online video contest
Shearer LS, Simmons L, Mindel A, Stanberry LR, Rosenthal SL, Sexual Health, 1/1/2012
Treatment with a novel topical nanoemulsion (NB-001) speeds time to healing of recurrent cold sores
Kircik L, Jones T, Jarratt M, Flack MR, Ijzerman M, Ciotti S, Sutcliffe J, Boivin G, Stanberry LR, Baker JR, and the NB-001 Study Group, J Drugs Dermatol, 1/1/2012
Parental reasons for utilization of an urban pediatric emergency department during the H1N1 influenza epidemic
Stockwell MS. Rausch J, Sonnett M, Stanberry LR, Rosenthal SL, Pediatric Emergency Care, 1/1/2011
A framework for faculty development
Rosenthal SL, Stanberry LR, J Pediatrics, 1/1/2011
Perceptions of reimbursement for clinical trial participation
Radecki-Breitkopf C, Loza M, Vincent K, Moench T, Stanberry LR, Rosenthal SL, J Empirical Res Hum Res Ethics, 1/1/2011
Optical coherence tomography for assessment of epithelial toxicity after use of vaginal products: a randomized clinical study
Vincent KL, Stanberry LR, Moench TR, Radecki-Breitkopf C, Loza ML, Wei J, Grady J, Paull J, Motamedi M, Rosenthal SL, Obstetrics Gynecol, 1/1/2011
Perceptions of Reimbursement for Clinical Trial Participation J Empirical Res Hum Res Ethics 6:31-38, 2011 Vincent KL, Stanberry LR, Moench TR, Radecki-Breitkopf C, Lo...
Radecki-Breitkopf C, Loza M, Vincent K, Moench T, Stanberry LR, Rosenthal SL, Obstetrics Gynecol, 1/1/2011
Prevention strategies for herpes zoster and post-herpetic neuralgia
Levin MJ, Gershon A, Dworkin RH, Brisson M, Stanberry L, Journal of Clinical Virology, 1/1/2010
2010 Sexually Transmitted Diseases Treatment Guidelines
Centers for Diseases Control and Prevention, Morbidity and Mortality Weekly Report, 1/1/2010
High resolution confocal imaging of vaginal epithelial microstructure can detect damage following topical application of N-9 containing gel
Vargas G, Shilagard T, Johnston R, Bell B, Stegall R, Vincent K, Stanberry L, Motamedi M, Bourne N, J Infect Dis, 1/1/2009
High resolution imaging of epithelial injury in the sheep cervicovaginal tract: A promising model for testing safety of candidate microbicides
Vincent KL, Bourne N, Bell BA, Cowan DF, Tan A, Vargas G, Stanberry LR, Rosenthal SL, Motamedi M, Sex Trans Dis, 1/1/2009
Prevention of mother-to-child transmission of viral infections
Read JS, Cannon MJ, Stanberry LR, Schuval S, Current Problems in Pediatric and Adolescent Health Care, 1/1/2008
Human monoclonal antibody (AVP-21D9) to protective antigen reduces the dissemination of Bacillus anthracis Ames strain from the lungs in a rabbit model
Peterson JW, Comer JE, Baze WB, Noffsinger DM, Wenglikowski A. Walberg KG, Hardcastle J, Pawlik J, Bush K, Taormina J, Moen S, Thomas J, Chatuev BM, Sower L,. Chopra ..., Infect Immun, 1/1/2007
Short-course therapy for recurrent genital herpes and herpes labilalis
Spruance S, Aoki FY, Tyring S, Stanberry L, Whitley R, Hamed K, Journal of Family Practice, 1/1/2007
VivaGel™ (SPL7013 Gel): A candidate dendrimer-microbicide for the prevention of HIV and HSV infection
Rupp R, Rosenthal SL, Stanberry LR, Int J Nanomedicine, 1/1/2007
Review of recent HSV recurrent infection treatment studies
Patel R, Stanberry LR, Whitley RJ, Herpes, 1/1/2007
An update on short-course, episodic and prevention therapies for herpes genitalis
Corey L, Bodsworth N, Mindel A, Patel R, Schacker T, Stanberry L, Herpes, 1/1/2007
Estimating the population prevalence of HPV [Invited Editorial]
Weller SC, Stanberry LR, JAMA, 1/1/2007
Highlights of the 13th Annual Meeting of the International Herpes Management Forum [Editorial]
Stanberry L, Volpi A, Herpes, 1/1/2007
Join now to see all

Books/Book Chapters

Sexually Transmitted Diseases: Vaccines, Prevention, and Control
Chapter: Genital and Perinatal Herpes Simplex Virus
Page 273 - 314Stanberry LREditors: Stanberry LR, Rosenthal SL.Academic Press, LondonEdition Seco,2013
Sexually Transmitted Diseases: Vaccines, Prevention, and Control, London
Editors: Stanberry LR, Rosenthal SL.Academic PressEdition Seco,2013
Sexually Transmitted Diseases: Vaccines, Prevention, and Control
Chapter: The Epidemiology and Control of Human Papillomavirus Infection and Clinical Disease
Page 315 - 352Nyitray AG, Lu B, Kreimer AR, Anic G, Stanberry LR, Giuliano AREditors: Stanberry LR, Rosenthal SL.Academic Press, LondonEdition Seco,2013
Perspectives in Vaccinology: Understanding Modern Vaccines
Garçon N, Stern PL, Cunningham AL, Stanberry LRElsevier, London2011
Perspectives in Vaccinology: Understanding Modern Vaccines
Chapter: Vaccines of the Future
Page 151 - 199Stanberry LR, Strugnell REditors: Garçon N, Stern PL, Cunningham AL, Stanberry LR.Elsevier, London2011
Vaccines for Biodefense and Emerging and Neglected Diseases
Chapter: Vaccine Development Pathway
Page 45 - 54Stanberry LR, Barrett ABTEditors: Barrett ADT and Stanberry LR.Elsevier, London2009
Vaccines for Biodefense and Emerging and Neglected Diseases
Editors: Barrett ADT and Stanberry LR.Elsevier, London2009
New Generation Vaccines
Chapter: Herpes Simplex Vaccines
Page 653 - 671Koelle DM, Stanberry LR, Whitley RDEditors: Levine MM.Informa Healthcare, USA, Inc., New YorkEdition Four,2008
Vaccines
Chapter: Herpes Simplex Virus Vaccine
Page 1207 - 1212Stanberry LREditors: Plotkin SA, Orenstein WA, Offit PA.Saunders-Elsevier, PhiladelphiaEdition 5th,2008
International Encyclopedia of Public Health
Chapter: Herpes Virues
Page 382 - 389Stanberry LREditors: Heggenhougen K.Elsevier2008
Nelson Textbook of Pediatrics
Chapter: Herpes Simplex Virus
Page 1360 - 1366Stanberry LREditors: Behrman RE, Kliegman RM, and Jenson HB.W.B. Saunders Company, PhiladelphiaEdition 18th,2007
Behavioral Interventions for the Prevention and Control of Sexually Transmitted Diseases
Chapter: STI Vaccines: Status of Development, Potential Impact, and Important Factors for Implementation
Page 248 - 273Liddon N, Zimet GD, Stanberry LREditors: Aral SO, Douglas JM, Lipshutz JA.Springer, New York City2007
Understanding Herpes
Stanberry LRUniversity Press of Mississippi, Jackson, MississippiEdition 2nd,2006
Tropical Infectious Diseases; Principles, Pathogens & Practice
Chapter: Herpesviruses
Page 590 - 620Hudnall SD, Stanberry LREditors: Guerrant RL, Walker DH, Weller PF.Churchill Livingstone, PhiladelphiaEdition 2nd,2006
Infectious Diseases
Chapter: Herpes Simplex Viruses
Page 1905 - 1917Stanberry LR, Oxman MN, Simmons AEditors: SL Gorbach, JG Barlett and NR Blacklow Bartlett.Lippincott, Williams & Wilkins, PhiladelphiaEdition 3rd,2004
Infectious Diseases
Chapter: Genital Herpes
Page 904 - 915Simmons A, Oxman MN, Stanberry LREditors: SL Gorbach, JG Barlett and NR Blacklow Bartlett.Lippincott, Williams & Wilkins, PhiladelphiaEdition 3rd,2004
The Management of HSV-1 and Ocular HSV Diseases. Recommendations from the IHMF Management Strategies Workshop, 28-29 June 2001
Editors: Malkin J-E and Stanberry L.PPS Europe Ltd., London2002
Pediatric Infectious Diseases: Principles and Practice
Chapter: Perinatal Viral Infections
Page 1135 - 1147Brady RC, Stanberry LREditors: Jenson HB and Baltimore RS.W.B. Saunders Company, PhiladelphiaEdition 2nd,2002
Sexually Transmitted Diseases: Vaccines, Prevention, and Control
Stanberry LR and Bernstein DIAcademic Press, London2000
Herpes Genitale: Il virus, L'infezione E Il controllo
Chapter: Herpes Simplex Virus Vaccines
Page 159 - 182Stanberry L, Vandepapeliere PEditors: Volpi A.Il Pensiero Scientifico, Rome2000
Sexually Transmitted Diseases: Vaccines, Prevention, and Control
Chapter: Genital and Perinatal Herpes Simplex Virus Infections: Prophylactic Vaccines
Page 187 - 216Stanberry LREditors: Stanberry LR and Bernstein DI.Academic Press, London2000
Nelson Textbook of Pediatrics
Chapter: Varicella-Zoster Virus
Page 973 - 977Myers MG, Stanberry LREditors: Behrman RE, Kliegman RM, and Jenson HB.W.B. Saunders Company, PhiladelphiaEdition 16th,2000
Handbook of Animal Models of Infection
Chapter: Animal Models of Herpesvirus Genital Infection: Guinea Pig
Page 907 - 910Bourne N, Stanberry LREditors: Zak O and Sande M.Academic Press, London1999
Understanding Herpes
Stanberry LRUniversity Press of Mississippi, Jackson, Mississippi1998
Sexually Transmitted Diseases
Chapter: Herpes: Vaccines for HSV
Page 811 - 816Stanberry LREditors: Freedman D.WB Saunders Company, Philadelphia1998
Join now to see all

Lectures

Vaccine Development against HSV - Past, Current and Future
Fondation Merieux Conference Center, Annecy, France - 1/1/2012
What's New in HSV Prevention?
Montefiore Medical Center, New York - 1/1/2011
What We Have Learned and What We Do Not Know about HSV Vaccines
Venice, Italy - 1/1/2011
The HPV Vaccine Story
Orlando, Florida - 1/1/2011
Herpes Simplex Virus Vaccine Development: Lessons Learned
Kobe, Japan - 1/1/2009
HSV Pathogenesis, Neonatal and Genital Herpes and Vaccine Development
Indianapolis, Indiana - 1/1/2009
Vaccines for the Adolescent
Milan, Italy - 1/1/2008
Congenital and Perinatal HSV Infections
Honolulu, Hawaii - 1/1/2008
Vaccines and Microbicides
Chapel Hill, North Carolina - 1/1/2008
Herpes Simplex Virus Vaccine Development: Insights and Conundrums
Canberra, ACT, Australia - 1/1/2008
Lessons Learned in the Development of Herpes Simplex Virus Vaccines
Annecy, France - 1/1/2007
Why Has a Successful HSV Vaccine Been So Elusive?
Dubrovnik, Croatia - 1/1/2007
Questions Concerning the Development of Herpes Simplex Virus Vaccines
University of Pennsylvania, Philadelphia - 1/1/2007
Prospects for Genetic Immunization in Sexually Transmitted Diseases
Oxford, United Kingdom - 1/1/2006
Towards the Biomedical Control of Genital Herpes
University of Washington, Seattle, Washington - 1/1/2006
Pediatrics and Herpes Simplex Virus Vaccines
1/1/2005
Prophylactic and Therapeutic Herpes Simplex Virus Vaccine Strategies
Atlanta, Georgia - 1/1/2005
The Latest on Vaccines for Herpes and HPV
San Francisco, California - 1/1/2005
Microbicides in the Prevention of Genital Herpes
Bangkok, Thailand - 1/1/2005
Pathogenesis and Control of Genital Herpes
Turku, Finland - 1/1/2005
Current Status of HSV Vaccines. Herpes Simplex Virus Management: What to Do in 2004
Washington, D.C. - 1/1/2004
Prevention and Management of Neonatal Herpes & Sexually Transmitted Diseases in Adolescents
Texas Tech University Health Sciences Center, Lubbock, Texas - 1/1/2004
HSV Vaccine for Reproductive Age Women
Duke University, Durham, North Carolina - 1/1/2004
Genital Herpes Prevention
Indianapolis. Indiana - 1/1/2004
HSV Vaccines: Prospects and Challenges
Paris, France - 1/1/2003
Join now to see all

Other

Thesis Title: "Neuroendocrine-Endocrine Correlates to the Biological Behavior of Malignant Melanoma of the Syrian Hamster"
University of Illinois Medical Center
Chicago, Illinois - 1/1/1970

Press Mentions

Unfinished Business: Columbia Hosts 2nd COVID Vaccine SymposiumMarch 22nd, 2022
Millions of Children Miss Routine Vaccinations Amid Chaos of Covid-19: Urgent Catch-up Plans NeededSeptember 21st, 2021
UC Berkeley Bans 'Solo Outdoor Exercise' Amid Campus COVID-19 OutbreakFebruary 12th, 2021
Join now to see all

Grant Support

Evaluation Of Colposcopy For Use In Vaginal Product DevelopmentEunice Kennedy Shriver National Institute Of Child Health &Human Development2007
Adult AIDS Clinical Trial UnitNational Institute Of Allergy And Infectious Diseases2002–2003
Topical Microbicides &Biology Of Venereal PathogensNational Institute Of Allergy And Infectious Diseases2000–2003
Child Health Research Center-Developmental ImmunobiologyEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2002
Studies With Animal Models Of Sexually Transmitted DiseasesNational Institute Of Allergy And Infectious Diseases1995–2002
Topical Microbicides &Biology Of Venereal PathogensNational Institute Of Allergy And Infectious Diseases1999–2000
Viral Persistence--Studies With Herpes Simplex VirusNational Institute Of Allergy And Infectious Diseases1985–1999
Vanilloids And Hsv--Molecular And Structural AnalysisNational Institute Of Allergy And Infectious Diseases1995–1998
Topical Microbicides And Biology Of Venereal PathogensNational Institute Of Allergy And Infectious Diseases1995–1998
Molecular Analysis Of Neuronal HSV Latency/ReactivationNational Institute Of Allergy And Infectious Diseases1990–1994
Viral Persistence: Studies With Herpes Simplex VirusNational Institute Of Allergy And Infectious Diseases1989–1993

Research History

Physician-ScientistResearch has focused on vaccine, antiviral and microbicide development and the pathogenesis and immunobiology of herpes infections. Research funding from NIH, CDC, Gates Foundation and numerous vaccine, pharmaceutical and biotech companies.1982 - Present